fangchinoline has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, W; He, W; Jin, S; Li, J; Li, X; Lu, X; Qian, Y; Yang, W; Yang, Z | 1 |
| Guo, B; Li, X; Su, J; Wang, K; Zhang, T | 1 |
2 other study(ies) available for fangchinoline and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Bone Neoplasms; Carcinogenesis; Cell Movement; Cell Proliferation; Drugs, Chinese Herbal; Female; Humans; Mice, Inbred BALB C; Neoplasm Invasiveness; Osteosarcoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction | 2017 |
Fangchinoline as a kinase inhibitor targets FAK and suppresses FAK-mediated signaling pathway in A549.
Topics: Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Neoplasm Invasiveness; Phosphorylation; Signal Transduction | 2015 |